list of glp-1 receptor agonist America's Poison Centers GLP-1 Receptor Agonists Show Promise
Description
GIP, glucose-dependent insulinotropic polypeptide
Among those who have used these medications, 62% said it was to treat a chronic condition such as diabetes or heart disease, while 38% said they used them solely for weight loss
Obes Surg 2014
Phase 2 obesity trial data established retatrutide as the highest-performing weight-loss agent ever studied at that point in pharmaceutical development
Express Scripts (Evernorth) reports that GLP-1 drugs became the fastest-growing pharmacy benefit expenditure category in U.S
